DK0980251T3 - Vævsfaktor til påvirkning af blodkardannelse - Google Patents
Vævsfaktor til påvirkning af blodkardannelseInfo
- Publication number
- DK0980251T3 DK0980251T3 DK98933500T DK98933500T DK0980251T3 DK 0980251 T3 DK0980251 T3 DK 0980251T3 DK 98933500 T DK98933500 T DK 98933500T DK 98933500 T DK98933500 T DK 98933500T DK 0980251 T3 DK0980251 T3 DK 0980251T3
- Authority
- DK
- Denmark
- Prior art keywords
- tissue factor
- blood vessel
- vessel formation
- influence blood
- influence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Instructional Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19719652A DE19719652A1 (de) | 1997-05-09 | 1997-05-09 | Tissue-Faktor zur Förderung von Wundheilung |
| DEPCT/DE98/01278 | 1998-05-07 | ||
| PCT/DE1998/001306 WO1998051321A1 (de) | 1997-05-09 | 1998-05-08 | Tissue-faktor zur beeinflussung von gefässbildung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0980251T3 true DK0980251T3 (da) | 2002-11-18 |
Family
ID=7829124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98933500T DK0980251T3 (da) | 1997-05-09 | 1998-05-08 | Vævsfaktor til påvirkning af blodkardannelse |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0980251B1 (da) |
| JP (1) | JP2001527555A (da) |
| AT (1) | ATE222501T1 (da) |
| AU (1) | AU746782B2 (da) |
| CA (1) | CA2288117A1 (da) |
| CZ (1) | CZ293005B6 (da) |
| DE (2) | DE19719652A1 (da) |
| DK (1) | DK0980251T3 (da) |
| ES (1) | ES2184299T3 (da) |
| HU (1) | HUP0003831A3 (da) |
| IS (1) | IS5231A (da) |
| NO (1) | NO995459L (da) |
| PL (1) | PL336662A1 (da) |
| PT (1) | PT980251E (da) |
| SI (1) | SI0980251T1 (da) |
| WO (1) | WO1998051321A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7749498B2 (en) | 1997-03-10 | 2010-07-06 | Genentech, Inc. | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US20060235209A9 (en) | 1997-03-10 | 2006-10-19 | Jin-An Jiao | Use of anti-tissue factor antibodies for treating thromboses |
| US5986065A (en) | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US20030109680A1 (en) | 2001-11-21 | 2003-06-12 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| WO1994005328A1 (en) * | 1992-08-28 | 1994-03-17 | The Scripps Research Institute | Inhibition of tumor metastasis via neutralization of tissue factor function |
| FR2696095B1 (fr) * | 1992-09-30 | 1994-11-25 | Inoteb | Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application. |
| NZ271488A (en) * | 1994-07-12 | 1998-01-26 | Human Genome Sciences Inc | Connective tissue growth factor-2 (ctgf-2) |
| US5981471A (en) * | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
| DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
-
1997
- 1997-05-09 DE DE19719652A patent/DE19719652A1/de not_active Ceased
-
1998
- 1998-05-08 AU AU83315/98A patent/AU746782B2/en not_active Ceased
- 1998-05-08 CZ CZ19993912A patent/CZ293005B6/cs not_active IP Right Cessation
- 1998-05-08 CA CA002288117A patent/CA2288117A1/en not_active Abandoned
- 1998-05-08 ES ES98933500T patent/ES2184299T3/es not_active Expired - Lifetime
- 1998-05-08 PT PT98933500T patent/PT980251E/pt unknown
- 1998-05-08 DK DK98933500T patent/DK0980251T3/da active
- 1998-05-08 SI SI9830279T patent/SI0980251T1/xx unknown
- 1998-05-08 DE DE59805246T patent/DE59805246D1/de not_active Expired - Fee Related
- 1998-05-08 AT AT98933500T patent/ATE222501T1/de not_active IP Right Cessation
- 1998-05-08 EP EP98933500A patent/EP0980251B1/de not_active Expired - Lifetime
- 1998-05-08 JP JP54869198A patent/JP2001527555A/ja active Pending
- 1998-05-08 WO PCT/DE1998/001306 patent/WO1998051321A1/de active IP Right Grant
- 1998-05-08 HU HU0003831A patent/HUP0003831A3/hu unknown
- 1998-05-08 PL PL98336662A patent/PL336662A1/xx unknown
-
1999
- 1999-10-26 IS IS5231A patent/IS5231A/is unknown
- 1999-11-08 NO NO995459A patent/NO995459L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998051321A1 (de) | 1998-11-19 |
| PT980251E (pt) | 2003-01-31 |
| PL336662A1 (en) | 2000-07-03 |
| NO995459D0 (no) | 1999-11-08 |
| EP0980251A1 (de) | 2000-02-23 |
| IS5231A (is) | 1999-10-26 |
| SI0980251T1 (en) | 2003-02-28 |
| ES2184299T3 (es) | 2003-04-01 |
| AU746782B2 (en) | 2002-05-02 |
| CA2288117A1 (en) | 1998-11-19 |
| HUP0003831A3 (en) | 2003-08-28 |
| ATE222501T1 (de) | 2002-09-15 |
| WO1998051321A9 (de) | 1999-04-01 |
| CZ293005B6 (cs) | 2004-01-14 |
| JP2001527555A (ja) | 2001-12-25 |
| DE59805246D1 (de) | 2002-09-26 |
| EP0980251B1 (de) | 2002-08-21 |
| HUP0003831A2 (hu) | 2001-02-28 |
| AU8331598A (en) | 1998-12-08 |
| DE19719652A1 (de) | 1998-12-03 |
| NO995459L (no) | 1999-11-08 |
| CZ391299A3 (cs) | 2000-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944997L (no) | Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte | |
| DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
| DE69827192D1 (de) | Stent und Stent-Transplantat zur Behandlung von verzweigten Blutgefässen | |
| DK2412368T3 (da) | Sammensætning til behandling af ar | |
| TR199801390T2 (xx) | Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler | |
| NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
| DE69617963D1 (de) | Behandlung von titandioxidaufachlämmungen mittels scherkräften | |
| DK0706348T3 (da) | Kirurgisk instrument især til dental kirurgi. | |
| DK1178726T3 (da) | Vandig opløsning til konservering af væv og organer | |
| DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
| DK0980251T3 (da) | Vævsfaktor til påvirkning af blodkardannelse | |
| DK1331940T3 (da) | Anvendelse af det lange pentraxin PTX3 til behandling af sygdomme forårsaget af ændret aktivering af vækstfaktoren FGF-2 | |
| DK301190A (da) | Bioforenelige, stof-specifikke reagenser til behandling af fysiologiske vaesker | |
| DE3772051D1 (de) | Prothese zur expansion des hautgewebes. | |
| DE3785555D1 (de) | Verwendung von guaifenesin zur behandlung urologischer beschwerden. | |
| DE69519219D1 (de) | Verwendung von (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamid zur Behandlung von Keratopathie | |
| DE69832075D1 (de) | Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks | |
| FR2698534B1 (fr) | Fixateur externe modulaire pour ostéosynthèse des petits os, notamment de la main. | |
| NO984965L (no) | Komponent B som cicatrisant | |
| DE69819503D1 (de) | Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose | |
| ATE226443T1 (de) | Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation zur behandlung von pankreatitis | |
| UA32315A (uk) | Спосіб накладання шкірного шва | |
| ATE94759T1 (de) | Verwendung von dextransulfat, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen protatakarzinoms. | |
| DE69912778D1 (de) | Verwendung von wundverbänden zur behandlung von akuten wunden |